Bevacizumab and pulmonary embolism Patient Reports February 10, 2012

Bevacizumab Side Effects Report #5987747-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 24, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , hyperglycaemia, ketosis, oropharyngeal pain, pulmonary embolism , retching. Bevacizumab dosage: 620 MG, 2/WEEK. During the same period patient was treated with TEMSIROLIMUS. Patient recovered.

Bevacizumab Side Effects Report #5992815-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 26, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , hyperglycaemia, ketosis, pulmonary embolism . Bevacizumab dosage: 620 MG, 2/WEEK. During the same period patient was treated with TEMSIROLIMUS, DOMPERIDONE, CEFOTAXIME, HEPARIN, GLIMEPIRIDE, METFORMIN, ACTRAPID, WARFARIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6012466-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , hyperglycaemia, ketosis, pulmonary embolism . Bevacizumab dosage: 620 MG, 2/WEEK. During the same period patient was treated with TEMSIROLIMUS, DOMPERIDONE, CEFOTAXIME, HEPARIN, GLIMEPIRIDE, METFORMIN, ACTRAPID, WARFARIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6039336-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 31, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , diabetes mellitus, ketosis, pulmonary embolism . Bevacizumab dosage: 620 MG, 2/WEEK. During the same period patient was treated with TEMSIROLIMUS, DOMPERIDONE, CEFOTAXIME, HEPARIN, GLIMEPIRIDE, METFORMIN, ACTRAPID, WARFARIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #6098791-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 16, 2009. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , diabetes mellitus, ketosis, pulmonary embolism . Bevacizumab dosage: 620 MG, 2/WEEK. During the same period patient was treated with TEMSIROLIMUS, DOMPERIDONE, CEFOTAXIME, HEPARIN, GLIMEPIRIDE, METFORMIN, ACTRAPID, WARFARIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5127392-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 13, 2006. Male patient, weighting 213.4 lb, was diagnosed with rectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism . Bevacizumab dosage: 5MG/KG Q 2 WEEKS IV DRIP. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5665161-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 07, 2008. Male patient, weighting 186.1 lb, was diagnosed with prostate cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 10 MG/KG, D1, Q35D. During the same period patient was treated with SATRAPLATIN, PREDNISONE. Patient recovered.

Bevacizumab Side Effects Report #5675333-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 14, 2008. Male patient, weighting 186.1 lb, was diagnosed with prostate cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 10 MG/KG, D1, Q35D. During the same period patient was treated with SATRAPLATIN, PREDNISONE. Patient recovered.

Bevacizumab Side Effects Report #5986009-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2008. Male patient, 68 years of age, weighting 222.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pleural effusion, pulmonary embolism . Bevacizumab dosage: 1010MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.


Bevacizumab Side Effects Report #6011680-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 17, 2008. Male patient, 68 years of age, weighting 222.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: decubitus ulcer, deep vein thrombosis , dyspnoea, oedema peripheral, pleural effusion, pulmonary embolism , white blood cell count decreased. Bevacizumab dosage: 1010MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5622855-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2008. Female patient, 55 years of age, weighting 132.1 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, pulmonary embolism , thrombocytopenia. Bevacizumab dosage: 10MG/KG DAYS 1 AND 15 IV, OVER 30 MIN.. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5385290-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 09, 2007. Male patient, 52 years of age, weighting 172.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 10MG/M2 IV BOLUS. During the same period patient was treated with GEMCITABINE, ERLOTINIB D, ATIVAN, CELEXA, COLACE, LIDOCAINE, MIRALAX, OXYCODONE. Patient recovered.

Bevacizumab Side Effects Report #5775282-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 16, 2008. Female patient, 46 years of age, weighting 156.5 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ileus, pulmonary embolism . Bevacizumab dosage: 710MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5941603-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2008. Female patient, 46 years of age, weighting 156.5 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ileus, pulmonary embolism . Bevacizumab dosage: 710MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient died on 07/03/2008.


Bevacizumab Side Effects Report #5272635-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 20, 2007. Female patient, weighting 136.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism . Bevacizumab dosage: 15MG/KG EVERY 3 WEEKS IV DRIP. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5208959-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 11, 2007. Female patient, 62 years of age, weighting 94.00 lb, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, infection , lung neoplasm, metastases to lung, pain , pulmonary embolism . Bevacizumab dosage: 446.00 MG Q 2 WEEKS IV. Patient was hospitalized. Patient died on 08/28/2006.

Bevacizumab Side Effects Report #5331107-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 18, 2007. Male patient, weighting 174.2 lb, was diagnosed with oesophageal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atelectasis, pulmonary embolism , pulmonary infarction. Bevacizumab dosage: 10MG/MG2 IV BOLUS. During the same period patient was treated with DOCETAXEL D, CISPLATIN, IRINOTECAN, ATIVAN, DECADRON, EMEND, LACTLOSE, LOMOTIL. Patient recovered.

Bevacizumab Side Effects Report #5203701-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 05, 2007. Male patient, weighting 167.0 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 15 MG/KG EVERY 3 WEEKS IV. During the same period patient was treated with COUMADIN, OXYCONTIN, ATIVAN, ZOFRAN, OXYCODONE, DEXMETHASONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5203703-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 05, 2007. Male patient, weighting 164.0 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 15 MG/KG EVERY 3 WEEKS IV. During the same period patient was treated with OXYCODONE, COMBIVENT, DEXMETHASONE, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5143468-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 01, 2006. Male patient, 68 years of age, weighting 188.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism , radiation oesophagitis. Bevacizumab dosage: 15MG/KG, Q3WEEKS, IV. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4776907-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 21, 2005. Male patient, 63 years of age, weighting 199.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fibrin d dimer increased, lymphadenopathy, lymphangiosis carcinomatosa, malignant neoplasm progression, mesothelioma , metastatic neoplasm, peritoneal disorder, pulmonary embolism , rash . Bevacizumab dosage: 15MG/KG IV. During the same period patient was treated with ERLOTINIB, PREDNISONE, QUINAPRIL, LIPITOR, FOLIC ACID, IBUPROFEN, LOVENOX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5398941-4
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on July 24, 2007. Male patient, 53 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: oedema peripheral, oxygen saturation decreased, pain in extremity, pulmonary embolism . Bevacizumab dosage: 1320MG EVERY 3 WEEKS IV DRIP. During the same period patient was treated with CETUXIMAB, PACLETAXEL, CARBOPLATIN. Patient recovered.

Bevacizumab Side Effects Report #5575032-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 12, 2007. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism , vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMZAR, NOVALGIN, OMEPRAZOLE, FENTANYL, LERCANIDIPINE, JODID. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5583757-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 03, 2008. Male patient, weighting 203.8 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 930 MG Q 2WKS IV. During the same period patient was treated with GEMZAR, CARBOPLATIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5653841-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 19, 2008. Male patient, weighting 152.1 lb, was diagnosed with non-small cell lung cancer, pulmonary embolism  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE, HEPARIN. Patient died on 04/30/2007.

Bevacizumab Side Effects Report #5669964-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 05, 2008. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain , pulmonary embolism , vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMZAR, CARBOPLATIN, NOVALGIN, OMEPRAZOLE, FENTANYL, LERCANIDIPINE. Patient was hospitalized. Patient died on 01/07/2008.

Bevacizumab Side Effects Report #5705141-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 03, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, pulmonary embolism . Bevacizumab dosage: 770 MG, Q2W. During the same period patient was treated with GEMZAR, CARBOPLATIN, OXYCONTIN, OXYCODONE, ATIVAN, LIPITOR, METOPROLOL TARTRATE, ISOSORBIDE DINITRATE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5724194-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 18, 2008. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism , vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMZAR, CARBOPLATIN, NOVALGIN, OMEPRAZOLE, FENTANYL CITRATE, LERCANIDIPINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5911237-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 22, 2008. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism , vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with ERLOTINIB, CISPLATIN, GEMZAR, NOVALGIN, OMEPRAZOLE, FENTANYL, LERCANIDIPINE, JODID. Patient was hospitalized. Patient died on 01/07/2008.


Bevacizumab Side Effects Report #5922774-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 02, 2008. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, non-small cell lung cancer, pulmonary embolism , vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with ERLOTINIB, CISPLATIN, GEMZAR, NOVALGIN, OMEPRAZOLE, FENTANYL CITRATE, LERCANIDIPINE, JODID. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6008985-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 02, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure, febrile neutropenia, pulmonary embolism , tachycardia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, CISPLATIN, PANTOPRAZOLE, LASIX. Patient died.

Bevacizumab Side Effects Report #6023432-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 15, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure, febrile neutropenia, pulmonary embolism , tachycardia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, CISPLATIN, PANTOPRAZOLE, LASIX. Patient died.

Bevacizumab Side Effects Report #6017329-6
Bevacizumab side effect was reported by a Physician from SLOVAKIA (Slovak Republic) on Dec 19, 2008. Male patient, weighting 167.6 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism . Bevacizumab dosage: unknown. During the same period patient was treated with INTERFERON ALFA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6019231-2
Bevacizumab side effect was reported by a Physician from SLOVAKIA (Slovak Republic) on Dec 24, 2008. Male patient, weighting 167.6 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism . Bevacizumab dosage: unknown. During the same period patient was treated with INTERFERON ALFA. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #6052069-9
Bevacizumab side effect was reported by a Physician from SLOVAKIA (Slovak Republic) on Jan 15, 2009. Male patient, weighting 172.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism . Bevacizumab dosage: unknown. During the same period patient was treated with INTERFERON ALFA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6106591-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 26, 2009. Female patient, weighting 140.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hepatic enzyme increased, multi-organ failure, pneumonia , pulmonary embolism , renal failure acute. Bevacizumab dosage: 667 MG, Q2W. During the same period patient was treated with METOPROLOL, ALTACE, XANAX, CALCIUM, CRESTOR, ZOFRAN. Patient was hospitalized. Patient died.

Bevacizumab Side Effects Report #5498579-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 24, 2007. Female patient, 56 years of age, weighting 110.0 lb, was diagnosed with mesothelioma malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 15 MG/KG EVERY 21 DAYS IV. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5788964-5
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on June 25, 2008. Male patient, 65 years of age, weighting 132.3 lb, was diagnosed with lung neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cough, cytotoxic cardiomyopathy, fluid overload, left ventricular dysfunction, pulmonary embolism , right ventricular dysfunction, tachycardia, tachypnoea, wheezing. Bevacizumab dosage: 900MG MG OTHER IV. Patient recovered.

Bevacizumab Side Effects Report #5710454-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 10, 2008. Female patient, 49 years of age, was diagnosed with glioma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, pericardial effusion, pulmonary embolism . Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ENZASTAURIN, KEPPRA, EPINEPHRINE. Patient died on 03/25/2008.


Bevacizumab Side Effects Report #5387772-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2007. Male patient, 68 years of age, weighting 222.7 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , headache , lung infection, pulmonary embolism , pulmonary infarction, pyrexia. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, KEPPRA, ZOFRAN, LEXAPRO, DECADRON, PRILOSEC, REGLAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5229515-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 19, 2007. Male patient, 60 years of age, weighting 225.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abnormal behaviour, computerised tomogram abnormal, deep vein thrombosis , hydrocephalus , pulmonary embolism . Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5287046-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 23, 2007. Male patient, 60 years of age, weighting 225.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abnormal behaviour, deep vein thrombosis , hydrocephalus , neutrophil count decreased, pneumonia , pulmonary embolism , urinary tract infection . Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN, LEVAQUIN, THIAMINE HYDROCHLORIDE, DEXAMETHASONE, HEPARIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5904015-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 15, 2008. Female patient, 60 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, deep vein thrombosis , hypertension, pulmonary embolism . Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5370496-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 25, 2007. Male patient, 50 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pulmonary embolism , thrombocytopenia. Bevacizumab dosage: unknown. During the same period patient was treated with ETOPOSIDE, DECADRON, ZANTAC. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5903803-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 15, 2008. Female patient, 46 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , infection , intracranial hypotension, pulmonary embolism , wound decomposition. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with TEMOZOLOMIDE. Patient recovered.

Bevacizumab Side Effects Report #5518296-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 13, 2007. Male patient, weighting 306.4 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 1175MG QOW IV. During the same period patient was treated with IRINOTECAN, ATENOLOL, LEXAPRO, DECADRON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5520679-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 15, 2007. Male patient, weighting 306.4 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 1175MG QOW IV. During the same period patient was treated with IRINOTECAN, ATENOLOL, LEXAPRO, DECADRON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5636015-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2008. Male patient, weighting 185.2 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , haematochezia, hyperglycaemia, pulmonary embolism . Bevacizumab dosage: 10 MG/KG, IV Q2WKS. During the same period patient was treated with TEMOZOLOMIDE, LISINOPRIL, PEPCID, DEXAMETHASONE, FLONASE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5636602-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 19, 2008. Male patient, weighting 185.2 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , haematochezia, hyperglycaemia, pulmonary embolism . Bevacizumab dosage: 10 MG/KG, IV Q2WKS. During the same period patient was treated with TEMOZOLOMIDE, LISINOPRIL, PEPCID, DEXAMETHASONE, FLONASE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5793183-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 26, 2008. Male patient, weighting 249.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism . Bevacizumab dosage: 1125 MG. During the same period patient was treated with TEMOZOLOMIDE, LASIX, DECADRON, NEXIUM, TYLENOL W, SPIRONOLACTONE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5839083-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 31, 2008. Female patient, weighting 140.0 lb, was diagnosed with endometrial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: intestinal prolapse, pulmonary embolism . Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, ANZEMET, CIMETIDINE, DEXAMETHASONE, DIPHENHYDRAMINE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5991105-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with endometrial cancer, pulmonary embolism  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , failure to thrive, muscular weakness, pulmonary embolism . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5390631-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 04, 2007. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arteriospasm coronary, intestinal obstruction, pulmonary embolism , sepsis . Bevacizumab dosage: 510 MG, UNK. During the same period patient was treated with XELODA, NEXIUM, ACTONEL, TEMAZEPAM, ASPIRIN, SOLPRIN, PARIET, SALBUTAMOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5328032-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 17, 2007. Male patient, weighting 171.7 lb, was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, dysphagia, pulmonary embolism . Bevacizumab dosage: 390 MG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, PARACETAMOL, SEVREDOL, SENNA, MAXOLON, LACTULOSE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5474860-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 17, 2007. Male patient was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, pulmonary embolism . Bevacizumab dosage: 560 MG, QD. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CETUXIMAB, ASCAL, SELEKTINE, FOSINOPRIL. Patient was hospitalized. Patient died on 12/15/2006.

Bevacizumab Side Effects Report #5490047-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 03, 2007. Female patient was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: erythema, oedema peripheral, pain in extremity, pulmonary embolism . Bevacizumab dosage: 410 MG, UNK. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, MIXTARD, ATENOLOL, LIPITOR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5965105-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 12, 2008. Female patient was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, hypovolaemic shock, pulmonary embolism . Bevacizumab dosage: 7.5 MG/KG, ^2 IN 5 WK^. During the same period patient was treated with CETUXIMAB, OXALIPLATIN, IRINOTECAN HYDROCHLORIDE, FLUOROURACIL, LEUCOVORIN CALCIUM. Patient recovered.

Bevacizumab Side Effects Report #6008982-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 17, 2007. Male patient was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, pneumothorax, pulmonary embolism . Bevacizumab dosage: 560 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CETUXIMAB, ASCAL, SELEKTINE, FOSINOPRIL. Patient was hospitalized. Patient died on 12/15/2006.

Bevacizumab Side Effects Report #4735746-9
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Aug 01, 2005. Male patient, 77 years of age, weighting 169.8 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pain in extremity, pulmonary embolism . Bevacizumab dosage: 5 MG/KG IV Q 2 WEEKS. During the same period patient was treated with CAPECITABINE, IRINOTECAN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #4897381-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 30, 2006. Male patient, 73 years of age, weighting 141.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism , renal failure acute. Bevacizumab dosage: 5 MG /KG DAY 1 IV. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN, FLUOROURACIL, ERLOTINIB, ACTOS, COMPAZINE, GLIPIZIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4934938-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2006. Male patient, 73 years of age, weighting 141.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, bacteraemia, dehydration, dyspnoea, hypokalaemia, international normalised ratio increased, pulmonary embolism , renal failure acute, staphylococcal infection . Bevacizumab dosage: 5 MG/KG DAY 1 IV. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, ERLOTINIB, ACTOS, COMPAZINE, GLIPIZIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5464239-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 07, 2007. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: lung disorder, pulmonary embolism . Bevacizumab dosage: unknown. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN, FLUOROURACIL. Patient died on 09/08/2007.

Bevacizumab Side Effects Report #5483055-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 26, 2007. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alveolitis allergic, arterial spasm, cardiac failure, cardio-respiratory arrest, disease progression, pulmonary embolism , pulmonary hypertension , shock, tumour embolism. Bevacizumab dosage: unknown. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN, FLUOROURACIL. Patient recovered.

Bevacizumab Side Effects Report #6123849-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 18, 2009. Female patient, 43 years of age, weighting 232.6 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 10 MG/KG EVERY TWO WEEKS IV. During the same period patient was treated with ABRAXANE, PEPCID, PRILOSEC, PROTONIX, SIMETHICONE, DEXTRAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5567154-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 13, 2007. Female patient, weighting 169.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atelectasis, blood ph increased, mental status changes, pneumonia , pulmonary embolism , renal disorder, sputum discoloured. Bevacizumab dosage: 1550 MG, Q3W. During the same period patient was treated with ABRAXANE. Patient died on 12/04/2007.

Bevacizumab Side Effects Report #5626185-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 08, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 934 MG, 1/WEEK. During the same period patient was treated with SUNITINIB MALATE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5731876-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 01, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 934 MG, 1/WEEK. During the same period patient was treated with SUNITINIB MALATE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6018662-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 10, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, pleural effusion, pulmonary embolism . Bevacizumab dosage: 550 MG, UNK. During the same period patient was treated with PACLITAXEL, OMEPRAZOLE. Patient recovered.

Bevacizumab Side Effects Report #6019855-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 12, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism , pulmonary infarction. Bevacizumab dosage: 10 MG, UNK. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #6028166-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 31, 2008. Female patient, weighting 140.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 15 MG/KG EVERY 21 DAYS IV /041. During the same period patient was treated with TRASTUZUMAB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5426064-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2007. Female patient, weighting 198.0 lb, was diagnosed with bile duct cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 10MG/KG EVERY 15 DAYS IV. During the same period patient was treated with HYDROCHLOROTHIAZIDE, LEVOXYL, OXYCONTIN, OXYCODONE, MILK OF MAGNESIA, TYLENOL, SENNA, COLACE. Patient recovered.

Bevacizumab Side Effects Report #5287791-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 02, 2007. Male patient was diagnosed with anaplastic astrocytoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism , tenderness. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, KEPPRA, LEXAPRO, PROTONIX, DECADRON, DILANTIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5206956-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2007. Male patient, weighting 190.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain , pulmonary embolism . Bevacizumab dosage: 1720 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5213156-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2007. Female patient, weighting 195.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 440 MG. During the same period patient was treated with CAMPTOSAR, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5241595-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2007. Male patient, weighting 228.4 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism , venous thrombosis. Bevacizumab dosage: 518 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5243044-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, weighting 207.2 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 940 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5306011-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 20, 2007. Female patient, weighting 103.6 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 454 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5331136-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 18, 2007. Female patient, weighting 127.2 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism , vena cava thrombosis. Bevacizumab dosage: 290 MG. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5344166-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2007. Female patient, weighting 160.5 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 1445 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5358311-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2007. Male patient, weighting 174.2 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 745 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ELOXATIN, ASPIRIN, DIOVAN, FLAGYL, HYDROCHLOROTHIAZIDE, LIPITOR. Patient recovered.

Bevacizumab Side Effects Report #5078949-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 09, 2006. Male patient, weighting 144.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 1630 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5393816-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2007. Female patient, weighting 171.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , pulmonary embolism . Bevacizumab dosage: 790 MG. During the same period patient was treated with CAMPTOSAR, ARANESP, CRESTOR, DULCOLAX, GLYBURIDE, LANTUS, LARRY SOLUTION. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5400099-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2007. Male patient, weighting 215.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , disease progression, lung disorder, pulmonary embolism . Bevacizumab dosage: 1956 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL, COLACE, COMPAZINE, DEXEMETHASONE, LORAZEPAM, PERCOCET. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5443322-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2007. Female patient, weighting 209.7 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism . Bevacizumab dosage: 490 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5447366-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 05, 2007. Male patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , international normalised ratio decreased, pulmonary embolism . Bevacizumab dosage: 1100 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5467081-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 21, 2007. Male patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , international normalised ratio decreased, pulmonary embolism . Bevacizumab dosage: 1100 MG. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5469454-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2007. Female patient, weighting 209.7 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cyanosis, hyperhidrosis, pulmonary embolism . Bevacizumab dosage: 490 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5472048-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 18, 2007. Female patient, weighting 145.5 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation , ileus, pulmonary embolism . Bevacizumab dosage: 670 MG, DAYS 1+15. During the same period patient was treated with PACLITAXEL, ARIMIDEX, EFFEXOR, LOTREL, METOPROLOL SUCCINATE, NEXIUM, DECADRON, OXYGEN. Patient was hospitalized. Patient died on 03/01/2007.

Bevacizumab Side Effects Report #5693090-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 02, 2008. Female patient, weighting 138.9 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pleural effusion, pulmonary embolism . Bevacizumab dosage: 750 MG. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5888789-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 17, 2008. Female patient, weighting 244.5 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hepatic lesion, lung neoplasm, lymphadenopathy, pulmonary embolism . Bevacizumab dosage: 2244 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient recovered.

Bevacizumab Side Effects Report #5892770-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2008. Female patient, weighting 244.5 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: liver disorder, lung neoplasm, lymphadenopathy, pulmonary embolism . Bevacizumab dosage: 2244 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient recovered.

Bevacizumab Side Effects Report #6058434-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 27, 2009. Female patient, weighting 203.7 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: coagulopathy, pulmonary embolism , thrombosis. Bevacizumab dosage: 1825 MG. During the same period patient was treated with CAMPTOSAR, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient recovered.